Clinical trial
XIENCE Skypoint Large Vessel Post Approval Study
NCT05423379 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- XIENCE Skypoint Large Vessel Post Approval Study
- Lead sponsor
- Abbott Medical Devices
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- September 14, 2022
- Completion date
- August 30, 2027
- Enrollment
- 102 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.